This federal contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $113,151,099.41 definitive contract is a firm-fixed-price agreement to provide the ASPR with various bulk pharmaceutical products, including acyclovir sodium solution, doxycycline injection, meropenem, sodium chloride, and sterile water. The contract has a period of performance through March 13, 2030 and does not have a set-aside designation. Fresenius Kabi, LLC is a significant supplier of critical care pharmaceuticals to federal agencies, particularly the Department of Defense and Department of Veterans Affairs, and holds a large indefinite delivery contract with the VA National Acquisition Center for the cancer treatment drug bortezomib.
Generated 3/14/25, 9:59 AM